Altogether, it is apparent that AATs play a critical role in fulfilling the specific AA requirements in cancer cells, whereas the impact of oncogenic KRAS mutations on the expression and function of specific AATs in CRC cells are largely unknown. This evidence concerns the gene KRAS and colorectal carcinoma.